DE60124047D1 - Ferulasäure und Coffeinsäure oder Chlorogensäure enthaltende Zusammensetzungen zur Linderung von Bluthochdruck oder zur Verhinderung der Erhöhung des Blutdrucks - Google Patents

Ferulasäure und Coffeinsäure oder Chlorogensäure enthaltende Zusammensetzungen zur Linderung von Bluthochdruck oder zur Verhinderung der Erhöhung des Blutdrucks

Info

Publication number
DE60124047D1
DE60124047D1 DE60124047T DE60124047T DE60124047D1 DE 60124047 D1 DE60124047 D1 DE 60124047D1 DE 60124047 T DE60124047 T DE 60124047T DE 60124047 T DE60124047 T DE 60124047T DE 60124047 D1 DE60124047 D1 DE 60124047D1
Authority
DE
Germany
Prior art keywords
acid
preventing
increase
blood pressure
containing compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60124047T
Other languages
English (en)
Other versions
DE60124047T2 (de
Inventor
Atsushi Suzuki
Ryuji Ochiai
Ichiro Tokimitsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of DE60124047D1 publication Critical patent/DE60124047D1/de
Publication of DE60124047T2 publication Critical patent/DE60124047T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/145—Acids, anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60124047T 2000-08-07 2001-08-06 Ferulasäure und Coffeinsäure oder Chlorogensäure enthaltende Zusammensetzungen zur Linderung von Bluthochdruck oder zur Verhinderung der Erhöhung des Blutdrucks Expired - Lifetime DE60124047T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000238039A JP3548102B2 (ja) 2000-08-07 2000-08-07 高血圧症予防・治療剤
JP2000238039 2000-08-07

Publications (2)

Publication Number Publication Date
DE60124047D1 true DE60124047D1 (de) 2006-12-07
DE60124047T2 DE60124047T2 (de) 2007-06-06

Family

ID=18729805

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124047T Expired - Lifetime DE60124047T2 (de) 2000-08-07 2001-08-06 Ferulasäure und Coffeinsäure oder Chlorogensäure enthaltende Zusammensetzungen zur Linderung von Bluthochdruck oder zur Verhinderung der Erhöhung des Blutdrucks

Country Status (4)

Country Link
US (3) US7750053B2 (de)
EP (1) EP1186294B1 (de)
JP (1) JP3548102B2 (de)
DE (1) DE60124047T2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
US6991812B2 (en) * 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
WO2003074040A1 (fr) * 2002-03-05 2003-09-12 Kao Corporation Compositions servant a ameliorer les proprietes des matieres fecales
AU2003244134A1 (en) * 2002-06-28 2004-01-19 Kao Corporation Beverage
JP3769268B2 (ja) * 2002-06-28 2006-04-19 花王株式会社 飲料
KR20050073611A (ko) * 2002-11-06 2005-07-14 카오카부시키가이샤 혈액 유동성 개선제
JP4812222B2 (ja) * 2002-11-26 2011-11-09 花王株式会社 ミネラル吸収促進剤
FR2859629B1 (fr) * 2003-09-11 2008-05-16 Jean Noel Thorel Utilisation d'un compose de la famille des cycloartenols pour la preparation d'une composition destinee au traitement des rides et a l'amelioration ou au traitement du relief cutane
PL1716757T3 (pl) * 2004-01-30 2009-12-31 Kao Corp Kompozycja napoju kawy
JP5357372B2 (ja) * 2004-03-17 2013-12-04 花王株式会社 皮膚症状改善剤
JP2005330240A (ja) * 2004-05-21 2005-12-02 National Agriculture & Bio-Oriented Research Organization 抗高血圧剤
JP2006160721A (ja) * 2004-11-09 2006-06-22 Kao Corp 大脳疲労回復剤
TWI362245B (en) 2005-01-31 2012-04-21 Kao Corp Packaged coffee beverage
JP5039305B2 (ja) * 2005-02-28 2012-10-03 花王株式会社 予防的抗ストレス剤
KR20070107006A (ko) * 2005-02-28 2007-11-06 카오카부시키가이샤 예방적 항스트레스제
JP4955928B2 (ja) 2005-03-01 2012-06-20 花王株式会社 クロロゲン酸類組成物の製造方法
US8088428B2 (en) * 2005-03-16 2012-01-03 Kao Corporation Packaged coffee drink
JP2006306747A (ja) * 2005-04-27 2006-11-09 Nippon Menaade Keshohin Kk フキタンポポ抽出物を含有した生活習慣病予防または改善剤
TWI391099B (zh) 2005-07-29 2013-04-01 Kao Corp 容器裝牛奶咖啡飲料
JP3973674B2 (ja) 2005-07-29 2007-09-12 花王株式会社 容器詰ブラックコーヒー飲料
US8282973B2 (en) 2005-07-29 2012-10-09 Kao Corporation Container-packed milk coffee beverage
FR2904935A1 (fr) * 2006-08-18 2008-02-22 Centre Nat Rech Scient Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant).
JP4948384B2 (ja) * 2007-12-26 2012-06-06 キッコーマン株式会社 容器入り液体調味料
US20110045106A1 (en) * 2008-04-30 2011-02-24 Nestec S.A. Coffee extract
CN103794596B (zh) * 2012-10-29 2016-08-10 中芯国际集成电路制造(上海)有限公司 标准晶片及其制造方法
DE102014100534A1 (de) * 2014-01-17 2015-07-23 Pm-International Ag Pulverförmige Zusammensetzung zur Herstellung eines Nahrungsmittelersatzes
JP6167152B2 (ja) * 2015-10-29 2017-07-19 花王株式会社 上皮型ナトリウムチャネル活性化剤
WO2018207790A1 (ja) 2017-05-12 2018-11-15 花王株式会社 アミロイドβ分解排出促進剤
CA3078234A1 (en) 2017-10-06 2019-04-11 Cargill, Incorporated Readily dissolvable steviol glycoside compositions
CN108717095B (zh) * 2018-05-30 2020-06-23 四川新绿色药业科技发展有限公司 一种枇杷叶或含枇杷叶原料的药物的检测方法及鉴别、含量测定方法
US20210260013A1 (en) * 2018-07-11 2021-08-26 Aardvark Therapeutics lnc. Oral Pharmaceutical Formulations of Bitter Compounds for Pulmonary Hypertension
AU2020271793A1 (en) 2019-04-06 2021-11-04 Cargill, Incorporated Sensory modifiers
CN113784629A (zh) 2019-04-06 2021-12-10 嘉吉公司 用于制备植物提取物组合物的方法
CN110187041B (zh) * 2019-07-11 2021-03-26 上海凯宝药业股份有限公司 一种痰热清注射液指纹图谱的建立方法
US20220330595A1 (en) * 2019-09-30 2022-10-20 Maruzen Pharmaceuticals Co., Ltd. Angiotensin-converting enzyme inhibitor, blood pressure-lowering agent, and beverages and food products
CN112245418A (zh) * 2020-11-20 2021-01-22 南方医科大学 一种调整心力衰竭肠道微生物紊乱的药物及用途
CN116784446B (zh) * 2023-06-19 2023-12-08 中国农业大学 一种协同抑制铜绿假单胞菌的组合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US198807A (en) * 1878-01-01 Improvement in insect-powder injectors
JPS6140298A (ja) * 1984-06-30 1986-02-26 Zeria Shinyaku Kogyo Kk シクロアルテノ−ルフエルラ酸エステル−シクロデキストリン複合体
JPH04243822A (ja) 1991-01-24 1992-08-31 Tsumura & Co カルシウム拮抗剤
JPH04316597A (ja) 1991-04-12 1992-11-06 Kyokuto Internatl Corp トリテルペンアルコールのフェルラ酸エステル−分岐シクロデキストリン複合体
US5374441A (en) * 1992-02-04 1994-12-20 Rutgers, The State University Of New Jersey Heat stable fat substitute compositions and process
JPH08259453A (ja) 1993-12-06 1996-10-08 Nikka Uisukii Kk 果実ポリフェノール含有果汁とその製造方法、酸化防止剤、血圧降下剤、抗変異原性作用剤、アレルギー抑制剤、抗う蝕剤及び消臭剤
CA2128293C (en) * 1993-12-06 2002-09-03 Masayuki Tanabe Fruit polyphenols and medicinal compositions containing them
JP3521155B2 (ja) 1993-12-06 2004-04-19 ニッカウヰスキー株式会社 果実ポリフェノールの製造方法
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5955269A (en) * 1996-06-20 1999-09-21 Rutgers, The State University Of New Jersey Methods of screening foods for nutraceuticals
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
US5958417A (en) * 1996-10-24 1999-09-28 Hsu; Chau-Shin Herbal combinations
US6120823A (en) * 1997-10-28 2000-09-19 Lipton, Divsion Of Conopco, Inc. Flavoring materials used in foodstuffs
DE60026644T2 (de) 1999-09-22 2006-11-09 Kao Corp. Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
US6458392B1 (en) * 2000-07-12 2002-10-01 Kao Corporation Preventive, alleviative or remedy for hypertension
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
US6991812B2 (en) * 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
JP4243822B2 (ja) 2001-01-30 2009-03-25 日産化学工業株式会社 イソシアヌレート化合物とその製造方法
US20020187239A1 (en) * 2001-02-06 2002-12-12 Dusan Miljkovic Nutraceuticals and methods of obtaining nutraceuticals from tropical crops

Also Published As

Publication number Publication date
US20040043057A1 (en) 2004-03-04
JP2002053464A (ja) 2002-02-19
DE60124047T2 (de) 2007-06-06
JP3548102B2 (ja) 2004-07-28
US20040198807A1 (en) 2004-10-07
EP1186294A2 (de) 2002-03-13
EP1186294B1 (de) 2006-10-25
US7750053B2 (en) 2010-07-06
EP1186294A3 (de) 2003-05-21
US20020051810A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
DE60124047D1 (de) Ferulasäure und Coffeinsäure oder Chlorogensäure enthaltende Zusammensetzungen zur Linderung von Bluthochdruck oder zur Verhinderung der Erhöhung des Blutdrucks
WO2002080876A3 (fr) Utilisation d'un extrait d'algue phaeodactylum pour favoriser l'activite du proteasome des cellules de la peau
EE200100618A (et) Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks
PL345030A1 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome
ATE340844T1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
ATE269711T1 (de) Formulierung zur verwendung in der vorbeugung von pathogen-induzierten erkrankungen, einschliesslich hiv und hsv
DE60021266D1 (de) Verwendungen von zusammensetzungen zur behandlung oder vermeidung von schlafstörungen mit sehr niedrigdosierten cyclobenzaprine
PL354315A1 (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
HUP0102477A3 (en) Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases and pharmaceutical compositions containing the compounds
AU3398402A (en) Prevention of preservative uptake into biomaterials
ATE369851T1 (de) Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen
FR2788435B1 (fr) Utilisation d'un extrait d'un vegetal du genre rosmarinus dans des compositions destinees a traiter les signes cutanes du vieillissement
FR2812544B1 (fr) Utilisation d'au moins un extrait d'au moins un vegetal du genre salvia dans des compositions destinees a traiter les signes cutanes du vieillissement
IL157436A0 (en) Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
CL2003002356A1 (es) Compuestos derivados de 1-(1-acetil-piperidin-4-il)-(ester o amida)-4-(bencidrilo sustituido)-2-tert-butil-piperazina, composicion farmaceutica, y su uso en la inhibicion de 17b-hidroxiesteroide deshidrogenasa de tipo 3 y de enfermedades que dependen
DE60102122D1 (de) Zusammensetzung von Poly-1-Butenharz und dessen Verwendung
HUP0203721A3 (en) Novel hormonal composition and the use thereof
WO2004041173A3 (en) Compositions for darkening the skin and/or hair
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
EP1080724A4 (de) Zusammenstellung die die mpt-aktivität mindert
AU2001274407A1 (en) Benzophenones and sulfones as inhibitors of glycine uptake
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
DE69813083D1 (de) Kombination in feste Dosiermenge von Angiotensin-Converting-Enzyme-Hemmern mit Calcium-Kanal Antagonisten zur Behandlung von Herz-Kreislauferkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition